Fortress Biotech, Inc.
FBIO
$1.82
-$0.03-1.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.45% | 47.42% | -17.53% | 28.99% | -66.15% |
| Total Depreciation and Amortization | 5.87% | 17.55% | -19.65% | 0.00% | -0.08% |
| Total Amortization of Deferred Charges | -1.67% | -22.88% | -48.54% | 24.14% | 19.88% |
| Total Other Non-Cash Items | -308.12% | 50.04% | 61.94% | 44.68% | -89.45% |
| Change in Net Operating Assets | 48.02% | -17.79% | -52.47% | -156.35% | 131.21% |
| Cash from Operations | -51.57% | 35.65% | 8.15% | 13.98% | 27.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 107.77% | -- | -- | -- | -- |
| Total Debt Issued | -- | -85.14% | 573.36% | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | -- | -- | -- |
| Issuance of Common Stock | 66.91% | -91.63% | -- | -- | 20.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 100.00% | 0.00% | 0.00% |
| Other Financing Activities | 149.54% | 154.07% | -383.34% | -27.52% | -15.47% |
| Cash from Financing | 102.05% | 851.90% | -81.00% | -48.80% | -36.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,706.09% | 87.89% | -129.08% | -406.35% | -71.32% |